Product nameAnti-RNase 7 antibody
See all RNase 7 primary antibodies
DescriptionRabbit polyclonal to RNase 7
ab81470 reacts with a 17 kDa RNase 7 protein. It also cross reacts with Ribonuclease 8 protein.
Tested applicationsSuitable for: IHC-Fr, WBmore details
Species reactivityReacts with: Human
Synthetic peptide corresponding to Human RNase 7 (N terminal).
Protein previously labeled as Ribonuclease 7.
Storage instructionsShipped at 4°C. Upon delivery aliquot and store at -20°C. Avoid freeze / thaw cycles.
Storage bufferConstituent: Whole serum
Our Abpromise guarantee covers the use of ab81470 in the following tested applications.
The application notes include recommended starting dilutions; optimal dilutions/concentrations should be determined by the end user.
|IHC-Fr||1/200 - 1/1000.|
|WB||1/500 - 1/5000. Predicted molecular weight: 17 kDa.|
FunctionExhibits a potent RNase activity. Has broad-spectrum antimicrobial activity against many pathogenic microorganisms and remarkably potent activity (lethal dose of 90% < 30 nM) against a vancomycin resistant Enterococcus faecium.
Tissue specificityExpressed in various epithelial tissues including skin, respiratory tract, genito-urinary tract and, at a low level, in the gut. Expressed in liver, kidney, skeletal muscle and heart.
Sequence similaritiesBelongs to the pancreatic ribonuclease family.
- Information by UniProt
- EC 3.1.27.- antibody
- MGC133220 antibody
- Ribonuclease 7 antibody
All lanes : Anti-RNase 7 antibody (ab81470) at 1/500 dilution
Lane 1 : Human small intestine tissue lysate - total protein (ab29276)
Lane 2 : HeLa (Human epithelial carcinoma cell line) Whole Cell Lysate
Lysates/proteins at 10 µg per lane.
All lanes : Goat Anti-Rabbit IgG H&L (HRP) preadsorbed (ab97080) at 1/5000 dilution
Developed using the ECL technique.
Predicted band size: 17 kDa
Observed band size: 17 kDa
Additional bands at: 37 kDa, 40 kDa. We are unsure as to the identity of these extra bands.
Exposure time: 20 minutes
ab81470 has not yet been referenced specifically in any publications.